Competitive Analysis The Glucagon-like Peptide 1 (GLP-1) market is highly competitive, here are some of the top market players, Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer.Inc, Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd, Sun Pharmaceutical Industries Ltd
Units billed correspond precisely to actual mg administered (e.g., 300 mg = 30 units)
We want to see this research validated outside of the VA health system in more general populations, because the VA is largely made up of older white males, so we need to see if these findings are replicated in other patient populations, she says
Consistency matters, but for these two specifically, when you take them is as important as whether you take them